Here are four notes:
1. The company’s second quarter results surpassed the Zacks Consensus Estimate.
2. Integra LifeSciences has a 50-day moving average of $62.24 and a 200-day moving average of $59.00.
3. The company has a 52-week low of $42.09 and a 52-week high of $68.46.
4. Integra LifeSciences has a market cap of $2.05 billion and a PE ratio of 51.03.
More articles on devices:
Nextremity Solutions’ Arcus Staple System receives FDA approval: 4 quick facts
Blue Belt Technologies’ Navio system supports Smith & Nephew’s ZUK uni knee: 5 notes
Orchid acquires Alhenia coated orthopedic implant company: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
